EICHOR
● Active Not Recruiting
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
Condition: Knee Osteoarthritis · Synovitis of Knee · Sponsor: 4Moving Biotech
About this study
This phase 2a trial is an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of one single intra-articular (IA) injection of 4P004 or placebo in: * patients between 40 and 80 years of age, * with synovitis and grade 2 to 4 osteoarthritis (OA) of the knee according to Kellgren and Lawrence (KL) classification.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (22)
| Tucson Orthopaedic Institute | Tucson, Arizona, United States | — |
| Northwestern University Feinberg School of Medicine | Chicago, Illinois, United States | — |
| Skylight Health Research Burlington | Burlington, Massachusetts, United States | — |
| Durham Bone and Joint Specialists | Ajax, Canada | — |
| SJHC London Rheumatology Centre | London, Canada | — |
| G.R.M.O. (Groupe de recherche en maladies osseuses) Inc | Québec, Canada | — |
| Parker Institute Bispebjerg, Frederiksberg Hospital | Frederiksberg, Denmark | — |
| Sanos Clinic Herlev | Herlev, Denmark | — |
| CHU Montpellier | Montpellier, France | — |
| ChU de Nice | Nice, France | — |
| Hôpital Cochin | Paris, France | — |
| Hôpital Lariboisière | Paris, France | — |
+ 10 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07225829